Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.

Ozolins A, Narbuts Z, Strumfa I, Volanska G, Stepanovs K, Gardovskis J.

Medicina (Kaunas). 2012;48(10):507-14.

PMID:
23324246
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.

Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS.

Pathol Res Pract. 2000;196(8):533-40.

PMID:
10982016
[PubMed - indexed for MEDLINE]
3.

[Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].

Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):212-6. Chinese.

PMID:
15256110
[PubMed - indexed for MEDLINE]
4.

Potential diagnostic utility of CD56 and claudin-1 in papillary thyroid carcinoma and solitary follicular thyroid nodules.

Abd El Atti RM, Shash LS.

J Egypt Natl Canc Inst. 2012 Dec;24(4):175-84. doi: 10.1016/j.jnci.2012.10.002. Epub 2012 Nov 6.

PMID:
23159288
[PubMed - indexed for MEDLINE]
Free Article
5.

Immunohistochemical diagnosis of papillary thyroid carcinoma.

Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.

Mod Pathol. 2001 Apr;14(4):338-42.

PMID:
11301350
[PubMed - indexed for MEDLINE]
Free Article
6.

Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.

Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.

Cancer. 1999 Jun 1;85(11):2475-84.

PMID:
10357421
[PubMed - indexed for MEDLINE]
7.

Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.

Coli A, Bigotti G, Parente P, Federico F, Castri F, Massi G.

J Exp Clin Cancer Res. 2007 Jun;26(2):221-7.

PMID:
17725102
[PubMed - indexed for MEDLINE]
8.

Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.

Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.

J Endocrinol Invest. 2004 Apr;27(4):311-7.

PMID:
15233548
[PubMed - indexed for MEDLINE]
9.

Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.

El Demellawy D, Nasr AL, Babay S, Alowami S.

Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.

PMID:
19153015
[PubMed - indexed for MEDLINE]
10.

HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.

Nga ME, Lim GS, Soh CH, Kumarasinghe MP.

Diagn Cytopathol. 2008 Aug;36(8):550-6. doi: 10.1002/dc.20841.

PMID:
18618720
[PubMed - indexed for MEDLINE]
11.

[Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].

Tong J, Wang Y, Da JP.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):599-604. Chinese.

PMID:
22325220
[PubMed - indexed for MEDLINE]
12.

Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.

Abd-El Raouf SM, Ibrahim TR.

Pathol Res Pract. 2014 Jun 27. pii: S0344-0338(14)00180-0. doi: 10.1016/j.prp.2014.06.010. [Epub ahead of print]

PMID:
25041837
[PubMed - as supplied by publisher]
13.

Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.

Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M.

Endocr Relat Cancer. 2005 Jun;12(2):305-17.

PMID:
15947105
[PubMed - indexed for MEDLINE]
Free Article
14.

Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.

Saleh HA, Jin B, Barnwell J, Alzohaili O.

Diagn Pathol. 2010 Jan 26;5:9. doi: 10.1186/1746-1596-5-9.

PMID:
20181018
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid.

El Demellawy D, Nasr A, Alowami S.

Diagn Pathol. 2008 Feb 6;3:5. doi: 10.1186/1746-1596-3-5.

PMID:
18254952
[PubMed]
Free PMC Article
16.

Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.

Park YJ, Kwak SH, Kim DC, Kim H, Choe G, Park do J, Jang HC, Park SH, Cho BY, Park SY.

J Korean Med Sci. 2007 Aug;22(4):621-8.

PMID:
17728499
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.

Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X.

J Clin Pathol. 2010 Sep;63(9):786-9. doi: 10.1136/jcp.2010.076901. Epub 2010 Jul 19.

PMID:
20644217
[PubMed - indexed for MEDLINE]
18.

[Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].

He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.

Zhonghua Bing Li Xue Za Zhi. 2008 Jan;37(1):35-9. Chinese.

PMID:
18509983
[PubMed - indexed for MEDLINE]
19.

[Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].

Bogdańska M, Górnicka B, Ziarkiewicz-Wróblewska B, Koperski L, Morton M, Wasiutyński A.

Endokrynol Pol. 2006 Jul-Aug;57(4):314-9. Polish.

PMID:
17006830
[PubMed - indexed for MEDLINE]
20.

Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.

Rossi ED, Raffaelli M, Mule' A, Miraglia A, Lombardi CP, Vecchio FM, Fadda G.

Histopathology. 2006 Jun;48(7):795-800.

PMID:
16722927
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk